Effects of Empagliflozin on Symptoms, Physical Limitations, and Quality of Life in Patients Hospitalized for Acute Heart Failure: Results From the EMPULSE Trial

Patients hospitalized for acute heart failure experience poor health status, including a high burden of symptoms and physical limitations, and poor quality of life. SGLT2 (sodium-glucose cotransporter 2) inhibitors improve health status in chronic heart failure, but their effect on these outcomes in...

Descripción completa

Detalles Bibliográficos
Autores principales: Kosiborod, Mikhail N., Angermann, Christiane E., Collins, Sean P., Teerlink, John R., Ponikowski, Piotr, Biegus, Jan, Comin-Colet, Josep, Ferreira, João Pedro, Mentz, Robert J., Nassif, Michael E., Psotka, Mitchell A., Tromp, Jasper, Brueckmann, Martina, Blatchford, Jonathan P., Salsali, Afshin, Voors, Adriaan A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311476/
https://www.ncbi.nlm.nih.gov/pubmed/35377706
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059725

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9311476/
https://www.ncbi.nlm.nih.gov/pubmed/35377706
http://dx.doi.org/10.1161/CIRCULATIONAHA.122.059725

Ejemplares similares